Josamycin and Rosamicin: In Vitro Comparisons with Erythromycin and Clindamycin
AUTOR(ES)
Shadomy, Smith
RESUMO
The macrolide antibiotics josamycin and rosamicin were compared in vitro with erythromycin for activity against Staphylococcus aureus, S. epidermidis, and enterococci and with clindamycin for activity against a variety of anaerobic organisms. Rosamicin and erythromycin were similar in activity and superior to josamycin against aerobic cocci. Most isolates of S. aureus (96%), S. epidermidis (79%), and the enterococci (87%) were inhibited by 1.56 μg of either of the new macrolide compounds per ml. Clindamycin was the most active compound against the anaerobic organisms.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=429829Documentos Relacionados
- In Vitro Activity of Josamycin and Rosamicin Against Bacteroides fragilis Compared with Clindamycin, Erythromycin, and Metronidazole
- Rosamicin: Evaluation In Vitro and Comparison with Erythromycin and Lincomycin
- Rosamicin: In Vitro Activity Against Anaerobes and Comparison with Erythromycin
- In Vitro Activity of Rosamicin, Josamycin, Erythromycin, and Clindamycin Against β-Lactamase-Negative and β-Lactamase-Positive Strains of Neisseria gonorrhoeae
- In Vitro Susceptibility Studies with Josamycin and Erythromycin